Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Peiyuan Yin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3639-3363; OpenAlex author ID A5072913663. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Prognostic and Diagnostic Value of Serum Bile Acid Profiles in Pancreatic Cancer: a Retrospective Multicenter Cohort Study. Last author DOI 10.1007/s12029-025-01283-z↗
  2. Multi-Omics Profiling Reveals Glycerolipid Metabolism-Associated Molecular Subtypes and Identifies ALDH2 as a Prognostic Biomarker in Pancreatic Cancer. Co-author DOI 10.3390/metabo15030207↗
  3. USP10 activates the FAK pathway by stabilizing RIOK3 in pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-3941004/v1↗
  4. Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer. Last author DOI 10.3389/fonc.2022.991051↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Henan Qin · 3 shared papers, 2022–2026 · strength 0.65
  2. Jiwei Liu · 2 shared papers, 2022–2024 · strength 0.34
  3. Chaoying Liu · 1 shared paper, 2026 · strength 0.32
  4. Jifeng Liu · 1 shared paper, 2025 · strength 0.27
  5. Dawei Deng · 1 shared paper, 2025 · strength 0.27
  6. Dong Shang · 1 shared paper, 2025 · strength 0.27
  7. Zhen Ning · 1 shared paper, 2024 · strength 0.19
  8. Shuang Li · 1 shared paper, 2024 · strength 0.19
  9. Rui Sun · 1 shared paper, 2024 · strength 0.19
  10. Chang Liu · 1 shared paper, 2022 · strength 0.15
  11. Aman Wang · 1 shared paper, 2022 · strength 0.15
  12. Haihua Liu · 1 shared paper, 2022 · strength 0.15
  13. Dong Shang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.